Yıl: 2019 Cilt: 52 Sayı: 2 Sayfa Aralığı: 162 - 166 Metin Dili: İngilizce İndeks Tarihi: 04-11-2020

THE MEFV VARIANTS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND THEIR CLINICAL CORRELATIONS

Öz:
INTRODUCTION: Familial Mediterranean Fever (FMF) isthe most common auto-inflammatory disease characterized byrecurrent attacks.FMF was found to be correlated with the mutationin MEFV gene. Patients with M694V homozygous mutation havebeen reported to have a more severe disease. However, there is noclear study of clinical correlation in other variants. In this study, weaimed to investigate the frequency and clinical correlation of MEFVgene variants.METHODS: Electronic medical records of FMF cohort wereretrospectively analyzed. FMF cohort was established in year 2010 andsince then all patients who fulfilled Tel-Hashomer criteria. Demographicinformation, attack characteristics, treatment information and MEFVgene outcomes of the patients were analysed using the records. InMEFV gene analysis, M694V, M694I, M680I, V726A, R761H, A744S,F479L, P369S, R202Q and E148Q variants are evaluated.RESULTS: A total of 605 patients were included in the study. Inpatients who had M694V mutation, arthritis and erysipelas wereobserved more frequently (p=0.04, p=0.008).Increased familyhistory of FMF was identified in patients with M694V mutation(p<0.001). In patients with M694V mutation, it was found that ageof onset of FMF symptoms, age of diagnosis, and age of treatmentinitiation were younger (p=0.003, p=0.014, p=0.025). In patients withM694Vhomozygous, frequency of amyloidosis was higher (p<0.001).The risk of developing amyloidosis was higher in M694Vhomozygous(Odds ratio 7.46, 95% confidence interval: 2.92-19.05).CONCLUSIONS: In conclusion, homozygous M694V mutationleads to severe disease. There was no clinical variability in otherMEFV gene variants
Anahtar Kelime:

AİLEVİ AKDENİZ ATEŞİ HASTALARINDA MEFV VARYANTLARI VE KLİNİK KORELASYONLARI

Öz:
AMAÇ: Ailesel Akdeniz Ateşi (FMF), tekrarlayan ataklarla karakterize en sık görülen oto-enflamatuar hastalıktır. MEFV genindeki mutasyonun FMF’e neden olduğu saptanmışır. M694V homozigot mutasyonu olan hastaların daha ciddi hastalığı olduğu bildirilmiştir. Ancak, diğer MEFV gen varyantların klinik korelasyonu ile ilgili net bir çalışma yoktur. Bu çalışmada, MEFV gen varyantlarının sıklığı ve klinik korelasyonunun araştırılması amaçlanmıştır. METOD: FMF kohortunun elektronik tıbbi kayıtları retrospektif olarak incelendi. Tel-Hashomer kriterlerine göre tanı konulan FMF hastalarının demografik bilgileri, atak özellikleri, tedavi bilgileri ve MEFV gen sonuçları hastaların kayıtları kullanılarak analiz edildi. MEFV gen analizinde, M694V, M694I, M680I, V726A, R761H, A744S, F479L, P369S, R202Q ve E148Q varyantları değerlendirildi. BULGULAR: Çalışmaya toplam 605 hasta dahil edildi. M694V mutasyonu olan hastalarda artrit ve erizipel daha sık gözlendi (p = 0.04, p = 0.008). M694V mutasyonu olan hastalarda artmış aile FMF öyküsü saptandı (p <0.001). M694V mutasyonu olan hastalarda FMF semptomlarının başlama yaşı, tanı yaşı ve tedavi başlama yaşının daha genç olduğu bulundu (p = 0.003, p = 0.014, p = 0.025). M694V homozigozlu hastalarda amiloidoz sıklığı daha yüksekti (p <0.001). M694V homozigozda amiloidoz gelişme riski daha yüksekti (Oran oranı 7.46, % 95 güven aralığı: 2.92-19.05). SONUÇ: Sonuç olarak, homozigot M694V mutasyonu şiddetli hastalığa yol açmaktadır. Diğer MEFV gen varyantları ile klinik arasında anlamlı ilişki saptanamadı.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1.)Gershoni-Baruch R, Brik R, Shinawi M, Livneh A (2002) The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 10 (2):145-149. doi:10.1038/sj.ejhg.5200776
  • 2.)Ben-Chetrit E, Touitou I (2012) The impact of MEFV gene identification on FMF: an appraisal after 15 years. Clin Exp Rheumatol 30 (3 Suppl 72):S3-6
  • 3.)French FMFC (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17 (1):25-31. doi:10.1038/ng0997-25
  • 4.)Tufan A, Babaoglu MO, Akdogan A et al. (2007) Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. J Rheumatol 34 (7):1540-1544
  • 5.)Chae JJ, Cho YH, Lee GS et al. (2011) Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice. Immunity 34 (5):755-768. doi:10.1016/j. immuni.2011.02.020
  • 6.)Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10 (2):417-426
  • 7.)Infevers (2018) The registry of familial Mediterranean fever (FMF) and hereditary autoinflammatory disorders mutations. http://fmf.igh.cnrs.fr/ISSAID/infevers/.
  • 8.)Fujikura K (2015) Global epidemiology of Familial Mediterranean fever mutations using population exome sequences. Mol Genet Genomic Med 3 (4):272-282. doi:10.1002/mgg3.140
  • 9.)Olgun A, Akman S, Kurt I, Tuzun A, Kutluay T (2005) MEFV mutations in familial Mediterranean fever: association of M694V homozygosity with arthritis. Rheumatol Int 25 (4):255-259. doi:10.1007/s00296-003-0433-x
  • 10.)Yalcinkaya F, Cakar N, Misirlioglu M et al. (2000) Genotypephenotype correlation in a large group of Turkish patients with familial mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology (Oxford) 39 (1):67-72
  • 11.)Ece A, Cakmak E, Uluca U et al. (2014) The MEFV mutations and their clinical correlations in children with familial Mediterranean fever in southeast Turkey. Rheumatol Int 34 (2):207-212. doi:10.1007/s00296-013-2858-1
  • 12.)Jarjour RA (2010) Familial Mediterranean fever in Syrian patients: MEFV gene mutations and genotype-phenotype correlation. Mol Biol Rep 37 (1):1-5. doi:10.1007/s11033-009-9475-9
  • 13.)Dewalle M, Domingo C, Rozenbaum M et al. (1998) Phenotypegenotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 6 (1):95-97. doi:10.1038/ sj.ejhg.5200170
  • 14.)Livneh A, Langevitz P, Zemer D et al. (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40 (10):1879-1885. doi:10.1002/1529-0131(199710)40:10<1879::AIDART23>3.0.CO;2-M
  • 15.)Taskiran EZ, Cetinkaya A, Balci-Peynircioglu B, Akkaya YZ, Yilmaz E (2012) The effect of colchicine on pyrin and pyrin interacting proteins. J Cell Biochem 113 (11):3536-3546. doi:10.1002/jcb.24231
  • 16.)Kasifoglu T, Bilge SY, Sari I et al. (2014) Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study. Rheumatology (Oxford) 53 (4):741-745. doi:10.1093/ rheumatology/ket400
  • 17.)Chae JJ, Wood G, Masters SL et al. (2006) The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci U S A 103 (26):9982-9987. doi:10.1073/pnas.0602081103
  • 18.)Pasa S, Altintas A, Devecioglu B et al. (2008) Familial Mediterranean fever gene mutations in the Southeastern region of Turkey and their phenotypical features. Amyloid 15 (1):49-53. doi:10.1080/13506120701815456
  • 19.)Coskun S, Kurtgoz S, Keskin E, Sonmez F, Bozkurt G (2015) Frequency of mutations in Mediterranean fever gene, with gender and genotype-phenotype correlations in a Turkish population. J Genet 94 (4):629-635
  • 20.)Bonyadi MJ, Gerami SM, Somi MH, Dastgiri S (2015) MEFV mutations in Northwest of Iran: a cross sectional study. Iran J Basic Med Sci 18 (1):53-57
  • 21.)Cekin N, Akyurek ME, Pinarbasi E, Ozen F (2017) MEFV mutations and their relation to major clinical symptoms of Familial Mediterranean Fever. Gene 626:9-13. doi:10.1016/j.gene.2017.05.013
  • 22.)Cattan D, Dervichian M, Thomas M, Dode C, Touitou I (2001) MEFV mutations and phenotype-genotype correlations in North African Jews and Armenians with familial Mediterranean fever. Isr Med Assoc J 3 (11):803-804
  • 23.)Samuels J, Aksentijevich I, Torosyan Y et al. (1998) Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore) 77 (4):268-297
  • 24.)Kone Paut I, Dubuc M, Sportouch J, Minodier P, Garnier JM, Touitou I (2000) Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatology (Oxford) 39 (11):1275-1279
  • 25.)Cazeneuve C, Sarkisian T, Pecheux C et al. (1999) MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 65 (1):88-97. doi:10.1086/302459
  • 26.)Soylemezoglu O, Arga M, Fidan K et al. (2010) Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation. J Rheumatol 37 (1):182-189. doi:10.3899/jrheum.090273
  • 27.)Akpolat T, Ozkaya O, Ozen S (2012) Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients. Gene 492 (1):285-289. doi:10.1016/j.gene.2011.10.012
  • 28.)Touitou I, Sarkisian T, Medlej-Hashim M et al. , International Study Group for Phenotype-Genotype Correlation in Familial Mediterranean F (2007) Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 56 (5):1706-1712. doi:10.1002/art.22507
  • 29.)Ong FS, Vakil H, Xue Y et al. (2013) The M694V mutation in Armenian-Americans: a 10-year retrospective study of MEFV mutation testing for familial Mediterranean fever at UCLA. Clin Genet 84 (1):55-59. doi:10.1111/cge.12029
APA VARAN Ö, Kucuk H, BABAOĞLU H, ATAŞ N, BİLİCİ SALMAN R, SATIŞ H, öztürk m, HAZNEDAROGLU S, Goker B, TUFAN A (2019). THE MEFV VARIANTS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND THEIR CLINICAL CORRELATIONS. , 162 - 166.
Chicago VARAN Özkan,Kucuk Hamit,BABAOĞLU Hakan,ATAŞ Nuh,BİLİCİ SALMAN Reyhan,SATIŞ Hasan,öztürk mehmet akif,HAZNEDAROGLU SEMINUR,Goker Berna,TUFAN Abdurrahman THE MEFV VARIANTS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND THEIR CLINICAL CORRELATIONS. (2019): 162 - 166.
MLA VARAN Özkan,Kucuk Hamit,BABAOĞLU Hakan,ATAŞ Nuh,BİLİCİ SALMAN Reyhan,SATIŞ Hasan,öztürk mehmet akif,HAZNEDAROGLU SEMINUR,Goker Berna,TUFAN Abdurrahman THE MEFV VARIANTS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND THEIR CLINICAL CORRELATIONS. , 2019, ss.162 - 166.
AMA VARAN Ö,Kucuk H,BABAOĞLU H,ATAŞ N,BİLİCİ SALMAN R,SATIŞ H,öztürk m,HAZNEDAROGLU S,Goker B,TUFAN A THE MEFV VARIANTS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND THEIR CLINICAL CORRELATIONS. . 2019; 162 - 166.
Vancouver VARAN Ö,Kucuk H,BABAOĞLU H,ATAŞ N,BİLİCİ SALMAN R,SATIŞ H,öztürk m,HAZNEDAROGLU S,Goker B,TUFAN A THE MEFV VARIANTS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND THEIR CLINICAL CORRELATIONS. . 2019; 162 - 166.
IEEE VARAN Ö,Kucuk H,BABAOĞLU H,ATAŞ N,BİLİCİ SALMAN R,SATIŞ H,öztürk m,HAZNEDAROGLU S,Goker B,TUFAN A "THE MEFV VARIANTS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND THEIR CLINICAL CORRELATIONS." , ss.162 - 166, 2019.
ISNAD VARAN, Özkan vd. "THE MEFV VARIANTS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND THEIR CLINICAL CORRELATIONS". (2019), 162-166.
APA VARAN Ö, Kucuk H, BABAOĞLU H, ATAŞ N, BİLİCİ SALMAN R, SATIŞ H, öztürk m, HAZNEDAROGLU S, Goker B, TUFAN A (2019). THE MEFV VARIANTS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND THEIR CLINICAL CORRELATIONS. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, 52(2), 162 - 166.
Chicago VARAN Özkan,Kucuk Hamit,BABAOĞLU Hakan,ATAŞ Nuh,BİLİCİ SALMAN Reyhan,SATIŞ Hasan,öztürk mehmet akif,HAZNEDAROGLU SEMINUR,Goker Berna,TUFAN Abdurrahman THE MEFV VARIANTS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND THEIR CLINICAL CORRELATIONS. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi 52, no.2 (2019): 162 - 166.
MLA VARAN Özkan,Kucuk Hamit,BABAOĞLU Hakan,ATAŞ Nuh,BİLİCİ SALMAN Reyhan,SATIŞ Hasan,öztürk mehmet akif,HAZNEDAROGLU SEMINUR,Goker Berna,TUFAN Abdurrahman THE MEFV VARIANTS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND THEIR CLINICAL CORRELATIONS. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, vol.52, no.2, 2019, ss.162 - 166.
AMA VARAN Ö,Kucuk H,BABAOĞLU H,ATAŞ N,BİLİCİ SALMAN R,SATIŞ H,öztürk m,HAZNEDAROGLU S,Goker B,TUFAN A THE MEFV VARIANTS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND THEIR CLINICAL CORRELATIONS. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi. 2019; 52(2): 162 - 166.
Vancouver VARAN Ö,Kucuk H,BABAOĞLU H,ATAŞ N,BİLİCİ SALMAN R,SATIŞ H,öztürk m,HAZNEDAROGLU S,Goker B,TUFAN A THE MEFV VARIANTS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND THEIR CLINICAL CORRELATIONS. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi. 2019; 52(2): 162 - 166.
IEEE VARAN Ö,Kucuk H,BABAOĞLU H,ATAŞ N,BİLİCİ SALMAN R,SATIŞ H,öztürk m,HAZNEDAROGLU S,Goker B,TUFAN A "THE MEFV VARIANTS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND THEIR CLINICAL CORRELATIONS." Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, 52, ss.162 - 166, 2019.
ISNAD VARAN, Özkan vd. "THE MEFV VARIANTS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND THEIR CLINICAL CORRELATIONS". Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi 52/2 (2019), 162-166.